The clinician's guide on monitoring children with asthma

Paediatric Respiratory Reviews

Volumn 14, Issue 2, 2013, Pages 119-125

  Brand, Paul L P ^a,b  

^a Princess Amalia children's Clinic   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Asthma control; Asthma monitoring; Exhaled nitric oxide; Lung function; Peak flow; Sputum eosinophils

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID; NITRIC OXIDE;

ASTHMA; CHILD; CLINICAL PRACTICE; CLINICAL RESEARCH; DAILY LIFE ACTIVITY; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; EOSINOPHIL; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; JOB EXPERIENCE; LUNG FUNCTION; MEDICAL DECISION MAKING; PATIENT INFORMATION; PATIENT MONITORING; PEAK EXPIRATORY FLOW; PLAY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT ALLERGY; REVIEW; SCORING SYSTEM; SPIROMETRY; SPORT; SPUTUM ANALYSIS; VALIDATION STUDY; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PROCEDURES;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; HUMANS; MONITORING, PHYSIOLOGIC; SPIROMETRY;

EID: 84878531248     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2012.07.001     Document Type: Review

References (71)

1. Boluyt N, Rottier BL, de Jongste JC, Riemsma R, Vrijlandt EJLE, Brand PLP: Assessment of Controversial Pediatric Asthma Management Options Using GRADE. Pediatrics 2012;in press.
2. Cuello Garcia C.A., Pacheco Alvarado K.P., Perez G.G. Grading recommendations in clinical practice guidelines: randomised experimental evaluation of four different systems. Arch Dis Child 2011, 96:723-728.
3. Brand P.L.P. Inhaled corticosteroids should be the first line of treatment for children with asthma. Paediatr Respir Rev 2011, 12:245-249.
4. Kuethe M.C., Vaessen-Verberne A.A., Bindels P.J., Van Aalderen W.M. Children with asthma on inhaled corticosteroids managed in general practice or by hospital paediatricians: is there a difference?. Prim Care Respir J 2010, 19:62-67. 8p.
5. Klok T., Brand P.L., Bomhof-Roordink H., Duiverman E.J., Kaptein A.A. Parental illness perceptions and medication perceptions in childhood asthma, a focus group study. Acta Paediatr 2011, 100:248-252.
6. Jentzsch N.S., Camargos P., Sarinho E.S., Bousquet J. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med 2012, 106:338-343.
7. Zhang Q., Taylor S.D., Sazonov V., Thomas M., Price D. Suboptimal persistence with inhaled corticosteroid monotherapy among children with persistent asthma in the UK. Prim Care Respir J 2011, 20:97-101.
8. Hasford J., Uricher J., Tauscher M., Bramlage P., Virchow J.C. Persistence with asthma treatment is low in Germany especially for controller medication - a population based study of 483 051 patients. Allergy 2010, 65:347-354.
9. Kaptein A.A., Hughes B.M., Scharloo M., et al. Illness perceptions about asthma are determinants of outcome. J Asthma 2008, 45:459-464.
10. Koster E.S., Wijga A.H., Koppelman G.H., et al. Uncontrolled asthma at age 8: The importance of parental perception towards medication. Pediatr Allergy Immunol 2011, 22(5):462-468.
11. Brouwer A.F.J., Brand P.L.P. Asthma education and monitoring: what has been shown to work. Paediatr Respir Rev 2008, 9:193-200.
12. Holt E.W., Cook E.F., Covar R.A., Spahn J., Fuhlbrigge A.L. Identifying the components of asthma health status in children with mild to moderate asthma. J Allergy Clin Immunol 2008, 121(5):1175-1180.
13. Brouwer A.F., Brand P.L., Roorda R.J., Duiverman E.J. Airway obstruction at time of symptoms prompting use of reliever therapy in children with asthma. Acta Paediatr 2010, 99(6):871-876.
14. Richardson L.P., Lozano P., Russo J., McCauley E., Bush T., Katon W. Asthma symptom burden: relationship to asthma severity and anxiety and depression symptoms. Pediatrics 2006, 118(3):1042-1051.
15. Wildhaber J., Carroll W.D., Brand P.L. Global impact of asthma on children and adolescents' daily lives: The room to breathe survey. Pediatr Pulmonol 2012, 47(4):346-357.
16. van Gent R., Essen-Zandvliet E.E., Klijn P., Brackel H.J., Kimpen J.L., Der Ent C.K. Participation in daily life of children with asthma. J Asthma 2008, 45(9):807-813.
17. Stevenson F.A., Cox K., Britten N., Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 2004, 7(3):235-245.
18. Roter D.L., Hall J.A. Communication and adherence: moving from prediction to understanding. Med Care 2009, 47(8):823-825.
19. Mauksch L.B., Dugdale D.C., Dodson S., Epstein R. Relationship, communication, and efficiency in the medical encounter: creating a clinical model from a literature review. Arch Intern Med 2008, 168(13):1387-1395.
20. Zolnierek K.B., DiMatteo M.R. Physician communication and patient adherence to treatment: a meta-analysis. Med Care 2009, 47(8):826-834.
21. Wilson S.R., Rand C.S., Cabana M.D., et al. Asthma outcomes: Quality of life. J Allergy Clin Immunol 2012, 129(3, Supplement):S88-S123.
22. Guilbert T.W., Garris C., Jhingran P., et al. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma 2011, 48:126-132.
23. Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., Townsend M. Measuring quality of life in children with asthma. Quality of Life Research 1996, 5:35-46.
24. Annett R.D., Bender B.G., Lapidus J., DuHamel T.R., Lincoln A. Predicting children's quality of life in an asthma clinical trial: what do children's reports tell us?. J Pediatr 2001, 139:854-861.
25. Goldbeck L., Koffmane K., Lecheler J., Thiessen K., Fegert J.M. Disease severity, mental health, and quality of life of children and adolescents with asthma. Pediatr Pulmonol 2007, 42:15-22.
26. Williams J., Williams K. Asthma-specific quality of life questionnaires in children: Are they useful and feasible in routine clinical practice?. Pediatr Pulmonol 2003, 35:114-118.
27. Cloutier M.M., Schatz M., Castro M., et al. Asthma outcomes: Composite scores of asthma control. J Allergy Clin Immunol 2012, 129(3, Supplement):S24-S33.
28. Liu A.H., Zeiger R., Sorkness C., et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007, 119:817-825.
29. Juniper E.F., Gruffydd-Jones K., Ward S., Svensson K. Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J 2010, 36:1410-1416.
30. de Blic J., Boucot I., Pribil C., Robert J., Huas D., Marguet C. Control of asthma in children: still unacceptable? A French cross-sectional study. Respir Med 2009, 103:1383-1391.
31. Piacentini G.L., Peroni D.G., Bodini A., et al. Childhood Asthma Control Test and airway inflammation evaluation in asthmatic children. Allergy 2009, 64:1753-1757.
32. Stanford R.H., Gilsenan A.W., Ziemiecki R., Zhou X., Lincourt W.R., Ortega H. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). J Asthma 2010, 47(3):257-262.
33. Ito Y., Adachi Y., Itazawa T., et al. Association between the Results of the Childhood Asthma Control Test and Objective Parameters in Asthmatic Children. J Asthma 2011, 48:1076-1080.
34. van Dalen C., Harding E., Parkin J., Cheng S., Pearce N., Douwes J. Suitability of forced expiratory volume in 1 second/forced vital capacity vs percentage of predicted forced expiratory volume in 1 second for the classification of asthma severity in adolescents. Arch Pediatr Adolesc Med 2008, 162:1169-1174.
35. de Groot E.P., Nijkamp A., Duiverman E.J., Brand P.L. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax 2012, 67:582-587.
36. Kaptein A.A., Klok T., Moss-Morris R., Brand P.L. Illness perceptions: impact on self-management and control in asthma. Curr Opin Allergy Clin Immunol 2010, 10:194-199.
37. Chipps B., Zeiger R.S., Murphy K., et al. Longitudinal validation of the test for respiratory and asthma control in kids in pediatric practices. Pediatrics 2011, 127:e737-e747.
38. Bousquet J., Mantzouranis E., Cruz A.A., et al. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010, 126(5):926-938.
39. Bateman E.D., Reddel H.K., Eriksson G., et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010, 125:600-608. 608.
40. Koster E.S., Raaijmakers J.A., Vijverberg S.J., et al. Limited agreement between current and long-term asthma control in children: the PACMAN cohort study. Pediatr Allergy Immunol 2011, 22:776-783.
41. Wu A.C., Tantisira K., Li L., Schuemann B., Weiss S.T., Fuhlbrigge A.L. Predictors of Symptoms Are Different From Predictors of Severe Exacerbations From Asthma in Children. Chest 2011, 140:100-107.
42. Jackson D.J., Sykes A., Mallia P., Johnston S.L. Asthma exacerbations: Origin, effect, and prevention. J Allergy Clin Immunol 2011, 128:1165-1174.
43. Forno E., Fuhlbrigge A., Soto-Quiros M.E., et al. Risk factors and predictive clinical scores for asthma exacerbations in childhood. Chest 2010, 138(5):1156-1165.
44. Rosychuk R.J., Voaklander D.C., Klassen T.P., Senthilselvan A., Marrie T.J., Rowe B.H. Asthma presentations by children to emergency departments in a Canadian province: a population-based study. Pediatr Pulmonol 2010, 45(10):985-992.
45. Covar R.A., Szefler S.J., Zeiger R.S., et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol 2008, 122(4):741-747.
46. Koolen B.B., Pijnenburg M.W., Brackel H.J., et al. Comparing Global Initiative for Asthma (GINA) criteria with the Childhood Asthma Control Test (C-ACT) and Asthma Control Test (ACT). Eur Respir J 2011, 38(3):561-566.
47. Carroll W.D., Wildhaber J., Brand P.L. Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey. Eur Respir J 2012, 39:90-96.
48. Brand P.L.P., Roorda R.J. Usefulness of monitoring lung function in asthma. Arch Dis Child 2003, 88:1021-1025.
49. Spahn J.D., Chipps B.E. Office-based objective measures in childhood asthma. J Pediatr 2006, 148:11-15.
50. Fuhlbrigge A.L., Weiss S.T., Kuntz K.M., Paltiel A.D. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics 2006, 118:e347-e355.
51. Stout J.W., Visness C.M., Enright P., et al. Classification of asthma severity in children: the contribution of pulmonary function testing. Arch Pediatr Adolesc Med 2006, 160:844-850.
52. Wensley D., Silverman M. Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial. Am J Respir Crit Care Med 2004, 170:606-612.
53. Deschildre A., Beghin L., Salleron J., et al. Home telemonitoring (forced expiratory volume in 1) in children with severe asthma does not reduce exacerbations s. Eur Respir J 2011, 39:290-296.
54. Kamps A.W.A., Roorda R.J., Brand P.L.P. Peak flow diaries in childhood asthma are unreliable. Thorax 2001, 56:180-182.
55. Yoos H.L., Kitzman H., McMullen A., Henderson C., Sidora K. Symptom monitoring in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with symptom monitoring. Ann Allergy Asthma Immunol 2002, 88:283-291.
56. Baatenburg de Jong A., Brouwer A.F.J., Roorda R.J., Brand P.L.P. Normal lung function in children with mild to moderate persistent asthma well controlled by inhaled corticosteroids. J Allergy Clin Immunol 2006, 118:280-282.
57. Stern D.A., Morgan W.J., Halonen M., Wright A.L., Martinez F.D. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008, 372:1058-1064.
58. Sears M.R., Greene J.M., Willan A.R., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003, 349:1414-1422.
59. Grol M.H., Gerritsen J., Vonk J.M., et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med 1999, 160:1830-1837.
60. van Essen-Zandvliet E.E.M., Hughes M.D., Waalkens H.J., Duiverman E.J., Pocock S.J., Kerrebijn K.F. Effects of 22 months of treatment with inhaled corticosteroids and/or β2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992, 146:547-554. Dutch CNSLD Study Group.
61. Scichilone N., Deykin A., Pizzichini E., Bellia V., Polosa R. Monitoring response to treatment in asthma management: food for thought. Clin Exp Allergy 2004, 34:1168-1177.
62. Nuijsink M., Hop W.C., Sterk P.J., Duiverman E.J., de Jongste J.C. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 2007, 30:457-466.
63. van Gent R., van der Ent C.K., Essen-Zandvliet L.E., et al. No differences in physical activity in (un)diagnosed asthma and healthy controls. Pediatr Pulmonol 2007, 42:1018-1023.
64. Garcia-Marcos L., Brand P.L. The utility of sputum eosinophils and exhaled nitric oxide for monitoring asthma control with special attention to childhood asthma. Allergol Immunopathol (Madr) 2010, 38(1):41-46.
65. Taylor D.R., Pijnenburg M.W., Smith A.D., de Jongste J.C. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006, 61:817-827.
66. Petsky H.L., Cates C.J., Lasserson T.J., et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012, 67:199-208.
67. Fleming L., Wilson N., Regamey N., Bush A. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012, 67:193-198.
68. Dweik R.A., Boggs P.B., Erzurum S.C., et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011, 184:602-615.
69. Grading quality of evidence and strength of recommendations. British Medical Journal 2004, 328:1490. GRADE working group.
70. Visser C.A., Brand P.L. Does a single measurement of exhaled nitric oxide predict asthma exacerbations?. Arch Dis Child 2011, 96(8):781-782.
71. Klok T., de Groot E.P., Brouwer A.F.J., Brand P.L.P. Follow-up of children with asthma. Eur Respir Mon 2012, 56:210-223.